Shanghai MicroPort Endovascular MedTech Group Co Ltd (MicroPort Endovascular MedTech), a subsidiary of MicroPort Scientific Corp, specializes in the research, development, manufacturing, sales, and services of aortic and peripheral vascular intervention devices. The company's product portfolio includes thoracic and abdominal aortic stent grafts, stent-grafts in surgical operations, drug-coated balloon dilatation catheters, peripheral vascular stents, and balloon dilatation catheters. The company operates under the brands Endovastec, Castor, Hercules, Minos, Aegis, CRONUS, Fontus and Talos. MicroPort Endovascular MedTech products are used in hospitals for the treatment of peripheral venous diseases, peripheral arterial diseases, and tumors. The company distributes its products through a network of hospitals in both domestic and international markets in Europe, Latin America, and Southeast Asia. MicroPort Endovascular MedTech is headquartered in Shanghai, China.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Shanghai MicroPort Endovascular MedTech Co Ltd
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Shanghai MicroPort Endovascular MedTech Co Ltd Company Overview
Shanghai MicroPort Endovascular MedTech Co Ltd Company Snapshot
Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
Shanghai MicroPort Endovascular MedTech Co Ltd – Pipeline Analysis Overview
Shanghai MicroPort Endovascular MedTech Co Ltd - Key Facts
Shanghai MicroPort Endovascular MedTech Co Ltd - Major Products and Services
Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products by Development Stage
Shanghai MicroPort Endovascular MedTech Co Ltd Ongoing Clinical Trials by Trial Status
Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products Overview
Shanghai MicroPort Endovascular MedTech Co Ltd - Key Competitors
Shanghai MicroPort Endovascular MedTech Co Ltd - Key Employees
Shanghai MicroPort Endovascular MedTech Co Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Shanghai MicroPort Endovascular MedTech Co Ltd, Recent Developments
Apr 07, 2024: MicroPort Endovastec Completes Its First Implantation of Cratos in Pre-Market Clinical Study in the EU and Japan
Mar 29, 2023: Endovastec Announces Annual Results for 2022
Jan 02, 2023: Endovastec completes first pre-market clinical implantation of TIPS Stent Graft System
Aug 25, 2022: Endovastec Announces 2022 Interim Results 25 Aug 2022
Apr 11, 2022: Endovastec receives MDSAP certificate for Brazil and Japan
Mar 29, 2022: Endovastec announces annual results for 2021
Mar 28, 2022: Hyperflex balloon catheter by Endovastec receives marketing approval in Japan
Nov 11, 2021: Vflower, first venous stent system by MicroPort Endovastec, gains access to China’s special approval procedure for innovative medical devices
Oct 16, 2021: Shanghai MicroPort Endovascular MedTech: Clinical trial enrollment completed for the first Endovastec Venous Stent
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products by Equipment Type
Table 3: Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products by Indication
Table 4: Shanghai MicroPort Endovascular MedTech Co Ltd, Key Facts
Table 5: Shanghai MicroPort Endovascular MedTech Co Ltd, Major Products and Services
Table 6: Shanghai MicroPort Endovascular MedTech Co Ltd Number of Pipeline Products by Development Stage
Table 7: Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products Summary by Development Stage
Table 8: Shanghai MicroPort Endovascular MedTech Co Ltd Ongoing Clinical Trials by Trial Status
Table 14: Cratos Branched Aortic Stent Graft System - A Prospective, Multicenter, Single-group Clinical Trial to Evaluate the Efficacy and Safety of the Cratos Branch Aortic Covered Stent System in the Treatment of Stanford Type B Aortic Dissection
Table 15: Cratos Branched Aortic Stent Graft System - Evaluation of Cratos Branch Stent Graft System in Treatment of Descending Aorta Lesions
Table 16: Multi-Branch Aortic Stent - Product Status
Table 22: TIPS Stent Graft System - Product Status
Table 23: TIPS Stent Graft System - Product Description
Table 24: TIPS Stent Graft System - A Prospective, Multicenter, Single-group, Target-value Trial to Evaluate the Safety and Efficacy of Tips Coated Stent System in the Treatment of Portal Hypertension
Table 25: Venous Stent - Product Status
Table 26: Venous Stent - Product Description
Table 27: Vewatch - Product Status
Table 28: Vewatch - Product Description
Table 29: Vflower Venous Stent System - Product Status
Table 30: Vflower Venous Stent System - Product Description
Table 31: Vflower Venous Stent System - Pre-market Multicenter Clinical Trial of the Vflower Venous Stent System
Table 32: Shanghai MicroPort Endovascular MedTech Group Co Ltd, Key Employees
Table 33: Glossary
List of Figures
Figure 1: Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products by Equipment Type
Figure 2: Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products by Development Stage
Figure 3: Shanghai MicroPort Endovascular MedTech Co Ltd Ongoing Clinical Trials by Trial Status